Incannex Healthcare Inc.
IXHL
$0.35
-$0.02-4.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 86.00K | 98.00K | 98.00K | 86.00K | 12.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.00K | 98.00K | 98.00K | 86.00K | 12.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 86.00K | 98.00K | 98.00K | 86.00K | 12.00K |
| SG&A Expenses | 13.13M | 14.70M | 16.57M | 18.31M | 17.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.12M | 20.63M | 22.14M | 23.34M | 18.62M |
| Operating Income | -22.03M | -20.53M | -22.05M | -23.25M | -18.61M |
| Income Before Tax | -46.89M | -21.71M | -23.78M | -23.12M | -18.43M |
| Income Tax Expenses | -- | 30.00K | 30.00K | 30.00K | 30.00K |
| Earnings from Continuing Operations | -46.89 | -21.74 | -23.81 | -23.15 | -18.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.89M | -21.74M | -23.81M | -23.15M | -18.46M |
| EBIT | -22.03M | -20.53M | -22.05M | -23.25M | -18.61M |
| EBITDA | -21.75M | -20.22M | -21.78M | -23.10M | -18.50M |
| EPS Basic | -1.22 | -1.22 | -1.40 | -1.40 | -1.14 |
| Normalized Basic EPS | -0.73 | -0.73 | -0.87 | -0.87 | -0.71 |
| EPS Diluted | -1.22 | -1.22 | -1.40 | -1.40 | -1.14 |
| Normalized Diluted EPS | -0.73 | -0.73 | -0.87 | -0.87 | -0.71 |
| Average Basic Shares Outstanding | 138.00M | 71.94M | 68.18M | 66.43M | 64.66M |
| Average Diluted Shares Outstanding | 138.00M | 71.94M | 68.18M | 66.43M | 64.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |